• Je něco špatně v tomto záznamu ?

Developmental programming of growth: genetic variant in GH2 gene encoding placental growth hormone contributes to adult height determination

Y. Timasheva, M. Putku, R. Kivi, V. Kožich, J. Männik, M. Laan,

. 2013 ; 34 (11) : 995-1001. [pub] 20130829

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20014869

Grantová podpora
070191/Z/03/A Wellcome Trust - United Kingdom

INTRODUCTION: Given the physiological role of placental growth hormone (PGH) during intrauterine development and growth, genetic variation in the coding Growth hormone 2 (GH2) gene may modulate developmental programming of adult stature. Two major GH2 variants were described worldwide, determined by single polymorphism (rs2006123; c.171 + 50C > A). We sought to study whether GH2 variants may contribute to adult anthropometric measurements. METHODS: Genotyping of GH2 SNP rs2006123 by RFLP, testing its genetic association with adult height and Body Mass Index (BMI) by linear regression analysis, and combining the results of three individual study samples in meta-analysis. STUDY SAMPLES: HYPEST (Estonia), n = 1464 (506 men/958 women), CADCZ (Czech), n = 871 (518/353); UFA (Bashkortostan), n = 954 (655/299); meta-analysis, n = 3289 (1679/1610). RESULTS: Meta-analysis across HYPEST, CADCZ and UFA samples (n = 3289) resulted in significant association of GH2 rs2006123 with height (recessive model: AA-homozygote effect: beta (SE) = 1.26 (0.46), P = 5.90 × 10⁻³; additive model: A-allele effect: beta (SE) = 0.45 (0.18), P = 1.40 × 10⁻²). Among men (n = 1679), the association of the A-allele with taller stature remained significant after multiple-testing correction (additive effect: beta = 0.86 (0.28), P = 1.83 × 10⁻³). No association was detected with BMI. Notably, rs2006123 was in strong LD (r² ≥ 0.87) with SNPs significantly associated with height (rs2665838, rs7209435, rs11658329) and mapped near GH2 in three independent meta-analyses of GWA studies. CONCLUSIONS: This is the first study demonstrating a link between a placental gene variant and programming of growth potential in adulthood. The detected association between PGH encoding GH2 and adult height promotes further research on the role of placental genes in prenatal programming of human metabolism.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20014869
003      
CZ-PrNML
005      
20200929120907.0
007      
ta
008      
200922s2013 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.placenta.2013.08.012 $2 doi
035    __
$a (PubMed)24035309
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Timasheva, Y $u Human Molecular Genetics Group, Institute of Molecular and Cell Biology, University of Tartu, Riia St. 23, Tartu 51010, Estonia; Institute of Biochemistry and Genetics, Ufa Scientific Centre of Russian Academy of Sciences, Ufa, Russia.
245    10
$a Developmental programming of growth: genetic variant in GH2 gene encoding placental growth hormone contributes to adult height determination / $c Y. Timasheva, M. Putku, R. Kivi, V. Kožich, J. Männik, M. Laan,
520    9_
$a INTRODUCTION: Given the physiological role of placental growth hormone (PGH) during intrauterine development and growth, genetic variation in the coding Growth hormone 2 (GH2) gene may modulate developmental programming of adult stature. Two major GH2 variants were described worldwide, determined by single polymorphism (rs2006123; c.171 + 50C > A). We sought to study whether GH2 variants may contribute to adult anthropometric measurements. METHODS: Genotyping of GH2 SNP rs2006123 by RFLP, testing its genetic association with adult height and Body Mass Index (BMI) by linear regression analysis, and combining the results of three individual study samples in meta-analysis. STUDY SAMPLES: HYPEST (Estonia), n = 1464 (506 men/958 women), CADCZ (Czech), n = 871 (518/353); UFA (Bashkortostan), n = 954 (655/299); meta-analysis, n = 3289 (1679/1610). RESULTS: Meta-analysis across HYPEST, CADCZ and UFA samples (n = 3289) resulted in significant association of GH2 rs2006123 with height (recessive model: AA-homozygote effect: beta (SE) = 1.26 (0.46), P = 5.90 × 10⁻³; additive model: A-allele effect: beta (SE) = 0.45 (0.18), P = 1.40 × 10⁻²). Among men (n = 1679), the association of the A-allele with taller stature remained significant after multiple-testing correction (additive effect: beta = 0.86 (0.28), P = 1.83 × 10⁻³). No association was detected with BMI. Notably, rs2006123 was in strong LD (r² ≥ 0.87) with SNPs significantly associated with height (rs2665838, rs7209435, rs11658329) and mapped near GH2 in three independent meta-analyses of GWA studies. CONCLUSIONS: This is the first study demonstrating a link between a placental gene variant and programming of growth potential in adulthood. The detected association between PGH encoding GH2 and adult height promotes further research on the role of placental genes in prenatal programming of human metabolism.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a tělesná výška $7 D001827
650    _2
$a index tělesné hmotnosti $7 D015992
650    12
$a vývoj kostí $7 D001846
650    _2
$a ženské pohlaví $7 D005260
650    12
$a vývoj plodu $7 D047109
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a růstový hormon $x genetika $x metabolismus $7 D013006
650    _2
$a lidé $7 D006801
650    _2
$a vazebná nerovnováha $7 D015810
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multigenová rodina $7 D005810
650    _2
$a placentární hormony $x genetika $x metabolismus $7 D010926
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a těhotenství $7 D011247
651    _2
$a Baškortostán $7 D001486
651    _2
$a Česká republika $7 D018153
651    _2
$a Estonsko $7 D004957
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Putku, M
700    1_
$a Kivi, R
700    1_
$a Kožich, V
700    1_
$a Männik, J
700    1_
$a Laan, M
773    0_
$w MED00003835 $t Placenta $x 1532-3102 $g Roč. 34, č. 11 (2013), s. 995-1001
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24035309 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200922 $b ABA008
991    __
$a 20200929120903 $b ABA008
999    __
$a ok $b bmc $g 1567729 $s 1105029
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 34 $c 11 $d 995-1001 $e 20130829 $i 1532-3102 $m Placenta $n Placenta $x MED00003835
GRA    __
$a 070191/Z/03/A $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20200922

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...